Back to Journals » Vascular Health and Risk Management » Volume 16

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

Total article views   HTML views PDF downloads Totals
2,417 Dovepress* 2,091+ 1,115 3,206
PubMed Central* 326 124 450
Totals 2,417 1,239 3,656
*Since 7 October 2020

View citations on PubMed Central and Google Scholar